QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.
Los Angeles, CA -- (SBWIRE) -- 10/05/2018 -- This study researches the market size of Glucagon Like Peptide-1 (GLP-1) Agonists, presents the global Glucagon Like Peptide-1 (GLP-1) Agonists sales and revenue by companies, regions, type and application, history breakdown data from 2013 to 2018, and forecast to 2025.
This report focuses on the key data information of Glucagon Like Peptide-1 (GLP-1) Agonists in key regions like North America, Europe, Asia Pacific, Central & South America, and Middle East & Africa, presents sales, revenue, market share, growth rate of Glucagon Like Peptide-1 (GLP-1) Agonists for each region and countries in each region.
For top companies, this report investigates and analyzes the sales, revenue, market share and growth rate for the top players, key data from 2013 to 2018.
This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
Request Sample Copy of Report@ https://www.qyresearch.com/sample-form/form/719752/global-glucagon-like-peptide-1-glp-1-agonists-industry-research-report-growth-trends-and-competitive-analysis
Glucagon like peptide-1 (GLP-1) agonists is the agonists of the GLP-1 receptor. This class of drugs is used for the treatment of type 2 diabetes. One of their advantages is over older insulin secretagogues, such as sulfonylureas or meglitinides, and they have a lower risk of causing hypoglycemia.
United States is the largest consumer of Glucagon like peptide-1 (GLP-1) agonists with the production market share of 35% and the consumption market share of 44% in 2015.
The second place is Europe, following North America with the production market share of 63% and the consumption market share of 28% in 2015.
Market competition is intense. Novo Nordisk, AstraZeneca, Eli Lilly, GSK, Sanofi are the leader of the industry, and hold the key technologies and patents, with high-end customers. They have formed global market channel of the industry. However, with the future expanding market, there will be more manufacturers in the future.
In 2018, the global Glucagon Like Peptide-1 (GLP-1) Agonists market size was 5240 million US$ and is forecast to 14200 million US in 2025, growing at a CAGR of 13.3% from 2018. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Glucagon Like Peptide-1 (GLP-1) Agonists.
This report includes the following manufacturers; we can also add the other companies as you want.
- Novo Nordisk
- AstraZeneca
- Eli Lilly
- GSK
- Sanofi
- Bristol-Myers Squibb
- Amylin
Request For Discount @ https://www.qyresearch.com/request-discount/form/719752/global-glucagon-like-peptide-1-glp-1-agonists-industry-research-report-growth-trends-and-competitive-analysis
Market Segment by Type
- Exenatied
- Liraglutide
- Lixisenatide
- Albiglutide
- Dulaglutide
Market Segment by Application
- Hospital
- Pharmacy
- Other
Benefits of Purchasing QY Research Report
- Analyst Support: Get you query resolved from our expert analysts before and after purchasing the report
- Customer's Satisfaction: Our expert team will assist with all your research needs and customize the report
- Inimitable Expertise: Analysts will provide deep insights about the reports
- Assured Quality: We focus on the quality and accuracy of the report
Buy Full Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/524193b6858fb0ff221fa3f7e4d567d1,0,1,Global%20Glucagon%20Like%20Peptide-1%20GLP-1%20Agonists%20Industry%20Research%20Report%252C%20Growth%20Trends%20and%20Competitive%20Analysis%202018-2025
About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.